American International Group’s Zomedica Corp. ZOM Stock Holding History

American International Group’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-28,131	Closed	-$10K	–	3196
2019 Q1	$10K	Buy	28,131 +986	+4%	+$870	﹤0.01%	3033
2018 Q4	$33K	Sell	27,145 -208	-0.8%	-$330	﹤0.01%	2969
2018 Q3	$51K	Buy	27,353 +1,647	+6%	+$3.52K	﹤0.01%	3062
2018 Q2	$58K	Buy	+25,706	New	+$51.6K	﹤0.01%	2961

Other funds holding ZOM

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

JVL Associates Wyoming, Michigan $352M AUM 27.55% 1-Year Est. Return

American International Group's ZOM Position: Q2 2019 in Review

American International Group sold out of Zomedica Corp. (ZOM) in Q2 2019, closing a stake of 28,131 shares — an estimated $10K sold.

American International Group first reported a position in ZOM in Q2 2018 and held it in 4 quarters. The position peaked at $58K in Q2 2018. 28 funds tracked by Wall St. Rank hold ZOM as of Q2 2019.

American International Group reported no remaining Zomedica Corp. position as of Q2 2019 after selling out during the quarter.
American International Group sold 28,131 Zomedica Corp. shares in Q2 2019, an estimated $10K.
American International Group first reported a position in Zomedica Corp. in Q2 2018 and held it in 4 quarters.
American International Group's Zomedica Corp. position peaked at $58K in Q2 2018.
28 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2019.

Based on American International Group's 13F filing for Q2 2019, filed 13 Aug 2019.